1. Home
  2. BANL vs ADXN Comparison

BANL vs ADXN Comparison

Compare BANL & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

N/A

Current Price

$0.46

Market Cap

11.7M

Sector

Energy

ML Signal

N/A

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$8.30

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANL
ADXN
Founded
2015
2002
Country
Malaysia
Switzerland
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
10.0M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BANL
ADXN
Price
$0.46
$8.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.8K
7.8K
Earning Date
09-04-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$580,456,800.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.38
N/A
52 Week Low
$0.40
$6.51
52 Week High
$1.30
$12.05

Technical Indicators

Market Signals
Indicator
BANL
ADXN
Relative Strength Index (RSI) 49.07 50.72
Support Level $0.44 $7.01
Resistance Level $0.48 $8.10
Average True Range (ATR) 0.02 0.42
MACD 0.01 0.01
Stochastic Oscillator 73.54 65.15

Price Performance

Historical Comparison
BANL
ADXN

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: